FDA NDC Directory · JSON-LD · Markdown

Methotrexate

NDC 0143-9830 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerHikma Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA040632
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRA-ARTERIAL INTRAMUSCULAR INTRATHECAL INTRAVENOUS
Active ingredientsMETHOTREXATE (1 g/1)
Marketing started20050906
Package count1

External sources

Source: openFDA. Public-domain (CC0).